Plain-English translation of NCT06526533 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
The RECOMMEND trial is testing whether one blood transfusion strategy works better than another for patients on ECMO — a machine that does the work of a failing heart or lungs while doctors try to help them recover. Right now, doctors use different approaches to deciding when and how much blood to give these very sick patients, and we don't have clear evidence about which approach is safest and most effective.
ECMO is a life-saving but risky treatment with serious complications, including bleeding and organ failure. Doctors need better evidence to guide everyday decisions like blood transfusions so they can improve survival and help patients recover better.
You likely qualify if…
You likely don't qualify if…
If you join this study, your medical team will randomly assign you to one of two blood transfusion strategies — either a more restrictive approach (giving blood only when absolutely necessary) or a more liberal approach (giving blood more readily). Your doctors will follow one of these strategies while you're on ECMO and monitor how you respond. The study is conducted as part of your regular ICU care, so you won't need extra visits beyond what's already planned.
AI-generated summary from trial data · Jun 28, 2026 · Not medical advice
Australia